A redox-responsive specific theranostic agent was developed by the conjugation of photosensitizers with the tryptophan-containing GE11 peptide via a cleavable disulfide linker. It showed a potential utility for the target-cell-specific activatable fluorescence imaging and photodynamic therapy of triple-negative breast cancers.